Androgen deprivation therapy plus abiraterone or docetaxel as neoadjuvant therapy for very-high-risk prostate cancer: a pooled analysis of two phase II trials

Objective: The study aimed to compare the efficacy and safety of androgen deprivation therapy (ADT) with abiraterone or docetaxel versus ADT alone as neoadjuvant therapy in patients with very-high-risk localized prostate cancer. Methods: This was a pooled analysis of two single-center, randomized, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Junlong, Wang, Yuwen, Zhang, Shun, Fu, Yao, Huang, Haifeng, Lyu, Xiaoyu, Zhang, Shiwei, Marra, Giancarlo, Xu, Linfeng, Qiu, Xuefeng, Guo, Hongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331422/
https://www.ncbi.nlm.nih.gov/pubmed/37435500
http://dx.doi.org/10.3389/fphar.2023.1217303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331422/
https://www.ncbi.nlm.nih.gov/pubmed/37435500
http://dx.doi.org/10.3389/fphar.2023.1217303

Ejemplares similares